The Food and Drug Administration has paved the way for commercial developers to create at-home COVID-19 tests. While no test is yet approved for home use, a fast and cheap test could encourage people to test themselves routinely before going to work or school. Real-time results would enable infected people to self-quarantine right away, keeping asymptomatic people from infecting others. "It fits with the modeling that’s been done where if you can test frequently enough that you could actually start to dampen down, if people would quarantine, you could dampen down cases. And that, as you know, would be huge," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group.
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the science behind at-home testing for COVID-19. Dr. Poland also shares the status of vaccine research trials, including how healthy adults can enroll in the COVID-19 vaccine clinical trial.
This interview was recorded on Aug. 3, 2020.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding along with guidelines and recommendations may have changed since the original publication date. For more information and all your COVID-19 coverage, go to [ Ссылка ] and [ Ссылка ].
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp., and Janssen Pharmaceuticals Inc. He is a paid scientific adviser for Johnson & Johnson. Honoraria: Elsevier.
